{
  "docId": "019dd923-622c-750b-8b9a-3bcd52c6e583",
  "docSlug": "f06b0b5d2079",
  "documentTitle": "Soleno Therapeutics (SLNO)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Scorpion Capital",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2025-08-15 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 186,
  "pageCount": 415,
  "prevPage": 185,
  "nextPage": 187,
  "slideType": "expose_contradiction",
  "function": "expose_contradiction",
  "density": "dense",
  "nDataPoints": 4,
  "notes": "The slide uses a Q&A format to present evidence of potential trial manipulation.",
  "elementsJson": [
    "paragraph",
    "quote_block",
    "footnote"
  ],
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-3bcd52c6e583/186",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-3bcd52c6e583",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-3bcd52c6e583.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-3bcd52c6e583#slide-186",
  "components": [
    {
      "bbox": {
        "h": 0.04,
        "w": 0.86,
        "x": 0.07,
        "y": 0.47
      },
      "kind": "callout",
      "text": "A handful of trial sites enrolled a substantial percentage of patients for phase 3 and the withdrawal study",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "22d2fd0f-5a08-4cb6-8ba1-5fc523c8a0d6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.86,
        "x": 0.07,
        "y": 0.51
      },
      "kind": "list",
      "text": "Q&A transcript excerpts detailing enrollment numbers and investigator behavior.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c1f299ff-18f1-4a9a-8318-146d214cf8c3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.86,
        "x": 0.07,
        "y": 0.19
      },
      "kind": "paragraph",
      "text": "Three ex-employees, two of whom were closely involved in the clinical trials, indicated that enrollment was heavily weighted to one site - Jennifer Miller - plus two others, and that they were suspicious of Miller's behavior – “Miller was the biggest enroller...I think Eric Felner was number 2”; “other than the top three, the rest of them had three or fewer”; “I think Felner and Miller probably had, out of the 77 that were in the withdrawal study, I think they probably had between 20 to 30 of them.” In the failed phase 3 study, the ex-employee estimated that the same top enrollers had “probably in the 40 to 50 ballpark between the three of them” out of ~127 total.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "27ef7182-0af7-4115-86ea-b32f666bd113",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.86,
        "x": 0.07,
        "y": 0.07
      },
      "kind": "paragraph",
      "text": "We can locate no peer-reviewed publication for the withdrawal study, highly unusual for an FDA-approved drug. We therefore presume the paper couldn't pass peer review, or that Soleno wishes to conceal the data from the public.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7b743da7-6e26-40a3-884a-be11f6f760fa",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "“Jennifer Miller was the biggest enroller...I think Eric Felner was number 2”; “I think other than the top three, the rest of them had three or fewer”; “I think Felner and Miller probably had, out of the 77 that were in the withdrawal study, I think they probably had between 20 to 30 of them.” — Formerly in a senior medical affairs role at Soleno",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-64ce-7561-b2a5-ba5dfa078a13",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.3,
        "x": 0.07,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Source: Scorpion Capital consultation calls with experts",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d496b5ce-b892-4d65-887b-79e05fc525d1",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "fraud-exposure",
      "slug": null,
      "matchId": "cbd85419-b363-4984-9aa7-cf0fb06d193d",
      "evidence": "The slide explicitly frames the lack of peer review and skewed enrollment as evidence of concealment and potential misconduct.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}